Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection
Clostridium difficile causes antibiotic- and healthcare-associated diarrhea, which is characterized by a high mortality rate (5–15%) and high recurrence rate of 20% or more. Therapeutic alternatives to antibiotics are urgently needed to improve the overall cure rate. Among these, therapeutic antibod...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2018-06-01
|
| シリーズ: | Frontiers in Microbiology |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/article/10.3389/fmicb.2018.01382/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|